Ziopharm Oncology | ZIOP - Ordinary Share Capital

Ziopharm Oncology reported $240K in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
AstraZeneca AZN:LN USD 387M 0
Baxter International BAX:US USD 683M 0
Biogen BIIB:US USD 100K 0
Bioline Rx BLRX:US USD 27.1M 5.94M
Corcept Therapeutics CORT:US USD 131K 1000
Curis CRIS:US USD 966K 2K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Immunogen IMGN:US USD 2.26M 52K
Intercept Pharmaceuticals ICPT:US USD 42K 1000
IONIS PHARMACEUT IONS:US USD 142K 0
Novartis NOVN:VX USD 890M 0
Ptc Therapeutics PTCT:US USD 72K 1000
Roche Holding ROG:VX 107M 0
Sangamo Biosciences SGMO:US USD 1.67M 49K
Tg Therapeutics TGTX:US USD 146K 1000
Verastem VSTM:US USD 20K 1000
YTE INCY:US USD 223K 1000
Ziopharm Oncology ZIOP:US USD 240K 24K